Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$7.70 – $17.25
97% from low
Exchange
OTC Link
OS
NEUREN PHARMS LTD ORD
No one on the platform currently holds NURPF.
No tracked institution reports a position in NURPF as of their last filing.
No one on the platform has traded NURPF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $107M | +58.1% | $0.29 | $0.13–$0.39 | 59.4× | 1 |
| 2027 | $176M | +64.5% | $0.57 | $0.26–$0.77 | 30.0× | 1 |
| 2028 | $233M | +32.8% | $0.95 | $0.44–$1.29 | 17.8× | 2 |
| 2029 | $761M | +225.9% | $3.62 | $1.66–$4.89 | 4.7× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 6 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-02-25 | $0.01 | $0.08 | +776.8% |
| 2025-08-26 | $0.08 | $0.08 | -0.3% |
| 2025-02-27 | $0.64 | $0.64 | -0.9% |
| 2024-08-27 | $0.07 | $0.04 | -44.0% |
| 2024-02-29 | $0.67 | $0.57 | -15.1% |
| 2023-06-30 | $0.21 | $0.24 | +14.5% |
| +0.74% |
| $8.2B |
| — |
| CMPXCompass Therapeutics, Inc. | $2.25 | -0.44% | $405M | — |
| CRNXCrinetics Pharmaceuticals, Inc. | $84.70 | +0.31% | $9.0B | — |
Source: Financial Modeling Prep · peers by sector/industry